India's Piramal joins Smith & Nephew board
This article was originally published in Clinica
Executive Summary
Ajay Piramal, chairman of the Indian conglomerate Piramal Group, will join Smith & Nephew's board as a non-executive director, effective 1 January 2012. Mumbai-based Piramal Group's activities span across a diverse range of industries – including healthcare, original drug discovery and financial services, among others – as well as across different geographic territories. Smith & Nephew indicated that Mr Piramal's industry and market knowledge, especially in areas such as India and China, will help the UK multinational achieve its growth plans for the emerging markets.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.